English  |  正體中文  |  简体中文  |  Items with full text/Total items : 16941/19260 (88%)
Visitors : 7630581      Online Users : 145
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.cnu.edu.tw/handle/310902800/2383

    標題: 磯松素和血根鹼對人類乳癌細胞增生抑制作用和細胞程式死亡機制之探討
    Plumbagin induces G2/M arrest and autophagy by inhibiting the AKT/mTOR pathway in breast cancer cells
    作者: 郭柏麟;Po-Lin Kuo
    貢獻者: 生物科技系
    關鍵字: 磯松素
    cell cycle
    日期: 2005
    上傳時間: 2008-07-31 14:37:40 (UTC+8)
    出版者: 台南縣:嘉南藥理科技大學生物科技系
    摘要: 本研究主要探討磯松素(plumbagin)的抗乳癌活性和相關分子機轉。結果發現磯松
    素會造成細胞週期停滯(cell cycle arrest)以及細胞自噬(autophagy)。磯松素促使細
    胞週期停滯於G2/M 期主要透過增加p21 表現、Chk2 活化以及降低cyclin B1、
    cyclin A、cdc2 和cdc25C 的表現。除此,磯松素還會透過增加p21 和Cdc2 的結
    合,以及增加Chk2 的活化促使Cdc2 和Cdc25C 的磷酸化而抑制Cdc2 的功能。
    松素可藉由抑制AKT 的活化以及相關下游分子,包括mammalian target of
    rapamycin (mTOR)、forkhead transcription factors (FKHR)和glycogen synthase
    kinase-3beta (GSK),有效的阻斷PI3K (phosphatidylinositol 3-kinase)/AKT 訊息傳
    遞。再者,mTOR 的數個下游分子,包括p70 ribosomal protein S6 kinase (p70S6
    kinase)和4E-BP1 的磷酸化也都一併受到抑制。當細胞過度表現AKT 時會抑制
    磯松素所造成的細胞自噬作用。相對的,當AKT 表現受到抑制時會明顯增加磯
    松素所造成的細胞自噬作用,因此證明磯松素透過AKT 的抑制作用促使啟動細
    胞自噬。除此,磯松素在裸鼠(nude mice)的研究也證實了其在in vivo 的條件下
    仍然具有抑制乳癌細胞增生、啟動細胞自噬以及抑制AKT 活化的能力。綜合以
    上結果,本研究證實磯松素可藉由抑制PI3K/AKT/mTOR 路徑促使細胞停滯以及
    This study is the first to investigate the anticancer effect of plumbagin in human
    breast cancer cells. Plumbagin exhibited cell proliferation inhibition by inducing cells
    to undergo G2/M arrest and autophagic cell death. Blockade of the cell cycle was
    associated with increased p21/WAF1 expression and Chk2 activation, and reduced
    amounts of cyclinB1, cyclinA, Cdc2 and Cdc25C. Plumbagin also reduced Cdc2
    function by increasing the association of p21/WAF1/Cdc2 complex and the levels of
    inactivated phospho-Cdc2 and phospho-Cdc25C by Chk2 activation. Plumbagin
    triggered autophagic cell death, but not, predominantly, apoptosis. Pretreatment of
    cells with autophagy inhibitor bafilomycin suppressed plumbagin-mediated cell death.
    We also found that plumbagin inhibited survival signaling through the PI3K
    (phosphatidylinositol 3-kinase)/AKT signaling pathway by blocking the activation of
    AKT and downstream targets, including the mammalian target of rapamycin (mTOR),
    forkhead transcription factors (FKHR) and glycogen synthase kinase-3beta (GSK).
    Phosphorylation of both of mTOR’s downstream targets, p70 ribosomal protein S6
    kinase (p70S6 kinase) and 4E-BP1, was also diminished. Overexpression of AKT by
    AKT cDNA transfection decreased plumbagin-mediated autophagic cell death,
    whereas reduction of AKT expression by siRNA potentiated plumbagin’s effect,
    supporting inhibition of AKT beneficial to autophagy. Furthermore, suppression of
    AKT by plumbagin enhanced the activation of Chk2, resulting in increased inactive
    phosphorylation of Cdc25C and Cdc2. Further investigation revealed that plumbagin’s
    inhibition of cell growth was also evident in a nude mice model. Taken together, these
    results imply a critical role for AKT inhibition in plumbagin-induced G2/M arrest and
    autophagy of human breast cancer cells.
    Appears in Collections:[生物科技系(所)] 國科會計畫

    Files in This Item:

    File Description SizeFormat
    NSC94-2320-B-041-007.pdf789KbAdobe PDF699View/Open

    All items in CNU IR are protected by copyright, with all rights reserved.

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback